Latest in Embattled Ev Maker
Sort by
10 items
-
-
Trump's Ukraine envoy calls Zelensky 'embattled and courageous leader'
President Trump's special envoy to Ukraine and Russia called Ukrainian President Volodymyr Zelensky an "embattled and courageous leader" after meetings in Kyiv on Friday, a notable shift from ...The Hill - 23h -
US envoy to Ukraine hails Zelenskyy as ‘embattled and courageous leader’
Keith Kellogg takes different tone from Trump, who contrasted ‘very good talks’ with Putin with cooler relationship with Ukraine’s leader. The US envoy to Ukraine, Gen Keith Kellogg, has praised ...The Guardian - 13h -
Nikola, Electric Truck Maker, Files for Bankruptcy
The company, which once enjoyed a surging stock price, struggled to turn its plans for electric and hydrogen trucks into a viable business.The New York Times - 2d -
HP to Buy Humane, Maker of the Ai Pin, for $116 Million
Humane, which marketed its Ai Pin as the next big thing after smartphones, had raised $240 million from investors, including OpenAI’s Sam Altman. The pin will be discontinued.The New York Times - 3d -
Troubled electric vehicle maker Nikola files for bankruptcy protection
Troubled electric vehicle maker Nikola is filing for for Chapter 11 bankruptcy protectionABC News - 3d -
With RFK Jr. in charge, supplement makers see chance to cash in
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion industry. Get ready for even less regulation.CBS News - 1d -
Scotch makers condemn English single malt whisky proposal
Scottish distilleries and MPs claim England's methods would damage the reputation of single malt.BBC News - 1d -
Google Ad-Tech Users Can Target National Security ‘Decision Makers’ and People With Chronic Diseases
Google enables marketers to target people with serious illnesses and crushing debt—against its policies—as well as the makers of classified defense technology, a WIRED investigation has found.Wired - 2d -
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.CNBC - 19h
